Immediate Impact

1 by Nobel laureates 3 from Science/Nature 62 standout
Sub-graph 1 of 22

Citing Papers

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Standout
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
2024 Standout
2 intermediate papers

Works of Thomas Secher being referenced

Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease
2022
Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy
2014

Author Peers

Author Last Decade Papers Cites
Thomas Secher 195 189 130 201 25 575
Nobuo Takasu 263 40 132 106 33 612
Kazuya Ikeda 292 49 54 135 21 527
Rachael S. Moulton 77 61 74 152 23 474
Kazufumi Honda 245 150 56 103 30 620
M Payet 394 138 46 211 39 640
Dan Lindholm 204 28 48 256 14 493
Kensuke Takatsuki 210 127 57 49 31 501
Ricco Lindner 419 45 73 209 17 602
Atsuro Oishi 288 101 72 151 19 549
Vittoria Spina‐Purrello 335 70 38 88 18 628

All Works

Loading papers...

Rankless by CCL
2026